Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
1,765.00    -13.00 (-0.73%)
Bid:
1,768.00
Ask:
1,771.00
Spread: 3.00 (0.17%)
Market Cap: £1.98b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Refinancing

1 Oct 2013 09:58

RNS Number : 3878P
Derwent London PLC
01 October 2013
 



1 October 2013

 

Derwent London signs new £550m five year unsecured bank facility

 

Derwent London ("Derwent London plc"/ "the Group") announces today that it has signed a new £550m unsecured five year revolving credit facility.

 

The new facility is being provided by the Group's principal relationship banks, HSBC, RBS, Barclays and Lloyds, with HSBC as agent. It replaces £650m of secured bank facilities expiring between April 2014 and January 2017, as was indicated in the Group's interim results announced in August and follows on from the Group's issue in July of £150m of convertible bonds due in July 2019.

 

The margin payable under the new facility is 160 basis points over LIBOR for net asset gearing levels of up to 50%. The margin increases at higher levels of gearing with a maximum permitted level of 160%. The current level of Group net asset gearing is 40.4% based on June 2013 property values.

 

Damian Wisniewski, Finance Director of Derwent London, commented:

 

"Our new unsecured bank facility brings greater operational flexibility in relation to individual properties and the release of security on the facilities repaid provides the Group with a pool of unencumbered assets of over £1.8bn. We are pleased to have put these new arrangements in place at competitive pricing."

 

-ends-

 

 

For further information please contact:

 

Derwent London 020 7659 3000

 

Damian Wisniewski, Finance Director

 

Louise Rich, Head of Investor Relations

 

 

Brunswick Group 020 7404 5959

 

Elizabeth Adams

 

Sheena Shah

 

 

 

Notes to editors

 

Derwent London

 

Derwent London plc owns a portfolio of commercial real estate predominantly in central London valued at £3.1bn as at 30 June 2013, making us the largest London-focused real estate investment trust (REIT).

Our experienced team has a proven record of value creation through development, refurbishment and asset management activities. We take a fresh approach to each building, adopting a design-led and tenant-led philosophy. We focus on buildings with reversionary mid-market rents, particularly those in improving locations around the West End and the City borders.

The business is grounded on a strong balance sheet with modest leverage, a robust income stream and flexible financing.

Landmark schemes in our portfolio of 5.5 million sq ft (510,600m2) as at 30 June 2013 include Angel Building EC1, The Buckley Building EC1, Qube W1, Horseferry House SW1 and Tea Building E1.

In 2013 to date Derwent London has won the 'West End Deal of the Year' for our letting to Burberry at 1 Page Street SW1 and 'City Development of the Year' for our 4 & 10 Pentonville Road N1 scheme at the OAS Development Awards as well as 'Developer of the Year' at the New Energy & Cleantech Awards. In addition the 2012 Report & Accounts and 2012 Sustainability Report have been awarded an EPRA Gold award

Derwent London came seventh overall in the 2012 Management Today awards for 'Britain's Most Admired Companies', topping the real estate sector for the third year in a row. Earlier in 2012 the Group won the Estates Gazette 'Property Company of the Year - Offices' award. Last year the Tea Building also won a RIBA regional award and an AJ Retrofit award for the 'Green Tea' refurbishment to improve the environmental performance of the building.

For further information see www.derwentlondon.com or follow us on Twitter at @derwentlondon.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAPEFESKDFEF
Date   Source Headline
29th Mar 201911:00 amRNSTotal Voting Rights
28th Mar 20197:00 amRNSBrunel Building Office Space Fully Pre-Let
21st Mar 201911:00 amRNSDirector/PDMR Shareholding
20th Mar 20191:30 pmRNSBlock listing Interim Review
15th Mar 20193:00 pmRNSHolding(s) in Company
13th Mar 201910:30 amRNSDirector/PDMR Shareholding
12th Mar 201910:00 amRNSDirector/PDMR Shareholding
5th Mar 201910:30 amRNSAdditional Listing
28th Feb 20195:00 pmRNSTotal Voting Rights
27th Feb 20199:30 amRNSHolding(s) in Company
26th Feb 20195:00 pmRNSDividend Declaration
26th Feb 20197:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2018
18th Feb 20199:00 amRNSHolding(s) in Company
31st Jan 20194:30 pmRNSTotal Voting Rights
28th Dec 20183:00 pmRNSTotal Voting Rights
13th Dec 20185:00 pmRNSHolding(s) in Company
30th Nov 20181:00 pmRNSTotal Voting Rights
30th Nov 201810:00 amRNSInvestor and Analyst Presentation and Tour
23rd Nov 20187:00 amRNSDirectorate Change
22nd Nov 20187:00 amRNS£250 Million US Private Placement
8th Nov 20187:00 amRNSQ3 2018 Business Update
7th Nov 20183:00 pmRNSHolding(s) in Company
31st Oct 20183:00 pmRNSTotal Voting Rights
17th Oct 201811:00 amRNSAdditional Listing
8th Oct 20189:43 amRNSChange of Credit Rating Agency
4th Oct 20184:00 pmRNSHolding(s) in Company
28th Sep 201811:00 amRNSTotal Voting Rights
20th Sep 20183:00 pmRNSBlock listing Interim Review
12th Sep 20185:30 pmRNSDirector/PDMR Shareholding
31st Aug 20181:00 pmRNSTotal Voting Rights
30th Aug 201811:00 amRNSAdditional Listing
28th Aug 20184:00 pmRNSDirector/PDMR Shareholding
9th Aug 20187:00 amRNSDirectorate Change
9th Aug 20187:00 amRNSHalf-year Results
31st Jul 201811:00 amRNSTotal Voting Rights
30th Jul 201810:00 amRNSHolding(s) in Company
4th Jul 201810:00 amRNSAdditional Listing
2nd Jul 201812:00 pmRNSHolding(s) in Company
29th Jun 20185:00 pmRNSDirector/PDMR Shareholding
29th Jun 20184:30 pmRNSTotal Voting Rights
14th Jun 20183:55 pmRNSSony Pictures Take Leading Role At Brunel Building
31st May 20181:00 pmRNSTotal Voting Rights
25th May 20183:00 pmRNSBlock listing Interim Review
18th May 201812:15 pmRNSResults of 2018 Annual General Meeting
16th May 201811:00 amRNSAdditional Listing
15th May 20185:30 pmRNSBondholders' meeting
10th May 20187:00 amRNSQ1 2018 Business Update
3rd May 20184:21 pmRNSAdjustment to Conversion Price
30th Apr 20186:20 pmRNSTotal Voting Rights
20th Apr 20185:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.